Organisation paid for research Program year 2025 Source: CMS Open Payments

Mayo CLNC Jacksonville

Neither a doctor nor a teaching hospital

Research payments

$541,336

63 payments

Through program year 2025, Mayo CLNC Jacksonville is reported as receiving $541,336 in research payments, across 63 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$51,631	13
2024	Research	$88,970	8
2023	Research	$31,426	10
2022	Research	$39,345	3
2021	Research	$132,411	7
2020	Research	$130,903	13
2019	Research	$66,650	9

Breakdown

Who paid Research payments · program years 2019–2025

Janssen Research & Development, LLC $343,378 52 payments
Siemens Medical Solutions USA, Inc. $176,977 4 payments
Actelion Pharmaceuticals, Ltd $20,981 7 payments

Studies the money was for Research payments · program years 2019–2025

17000139Blc2002 $109,330 10 payments
A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone DRd versus lenalidomide and Dexamethasone Rd in patients with newly diagnosed multiple myeloma who are not eligible for high dose chemotherapy and autologous stem cell transplant $104,845 15 payments
AIRC Workflow investigation $99,000 1 payment
A Phase 3 study comparing daratumumab . Lenalidomide and dexamethasone (DRd) versus lenalidomide and Dexamethasone (Rd) in patients with newly diagnosed multiple myeloma who are not eligible for high dose chemotherapy and autologous stem cell transplant $77,572 14 payments
AI Rad Companion workflow investigation $59,069 1 payment
A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder (SunRISe-4) $51,631 13 payments
The Efficacy and Safety of Initial Triple Versus Initial Dual Oral Combination Therapy in Patients With Newly Diagnosed Pulmonary Arterial Hypertension $20,981 7 payments
AI Rad Companion - Workflow investigation $18,250 1 payment
Mayo Clinic JacksonvilleWhiteChestSoftware EvaluationCT $658 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.